Rare earth-organic framework probe for ratio fluorescence detection of hepatotoxicity marker-ONOO-as well as preparation method and application of rare earth-organic framework probe
The rare earth-organic frame probe uses the fluorescence ratio method to eliminate environmental interference, and achieves rapid and accurate detection of ONOO-, which solves the problem of unsatisfactory detection effect in the existing technology. The detection limit reaches 5.4nM and can be used for small liver damage. The detection of ONOO- in mouse serum samples proves its credibility.
Patent Information
- Application Number
- CN202410962628.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-18
- Publication Date
- 2024-11-19
AI Technical Summary
The existing ONOO-detection fluorescent probes are susceptible to external environments such as biological background, excitation light fluctuations, environment and instruments, resulting in unsatisfactory detection results and it is difficult to accurately and quickly judge the existence of ONOO-.
The rare earth-organic frame probe is constructed by amino functionalized organic ligand and rare earth ions. The interference is eliminated through the fluorescence ratio method, and the presence of ONOO- is quickly and accurately judged by the fluorescence intensity and color changes, and the common salts and amino acids are used to treat common salts and amino acids. No response.
Fast and accurate detection of ONOO- is achieved, with a detection limit of 5.4 nM, which has good selectivity, and can be used for the detection of ONOO- in serum samples of liver-injured mice. The detection concentration is within the pathological range, which proves that ratio fluorescence is The credibility of detection.
Smart Images

Figure CN118978908A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of rare earth luminescence, and is specifically a method for detecting hepatotoxicity marker peroxynitrite (ONOO - ) Rare earth-organic framework probe for ratio fluorescence detection and its preparation method and application. Technical Background
[0002] As we all know, the liver is susceptible to damage from chemicals, alcohol or drugs. For example, paracetamol is a commonly used anti-pain / fever drug, the main ingredient of which is acetaminophen. Excessive use of acetaminophen can cause a large amount of reactive nitrogen to be produced in human mitochondria and blood, leading to severe liver toxicity. Liver toxicity is becoming a common disease that seriously endangers human health. However, there are no particularly obvious symptoms in the early stages of liver toxicity, so it is very easy to miss the best treatment period for liver toxicity. The clinical detection of liver toxicity is mainly through the detection of alanine aminotransferase and aspartate aminotransferase in the blood. However, since damage to the kidneys, heart and muscles can also increase the concentration of alanine aminotransferase and aspartate aminotransferase in the blood, the concentration of these two cannot accurately reflect the degree of liver damage, which can easily lead to misdiagnosis. Although pathological examination can directly reflect the condition of the liver, this method is time-consuming and requires professional operators, which limits its practical application. ONOO - As a common reactive nitrogen, ONOO in the normal human body - The concentration was less than 1×10 -6 M, ONOO under liver damage conditions - The concentration is close to 50-100×10 -6 M, therefore, is considered to be an effective biomarker for hepatotoxicity, and tracking the concentration changes of ONOO- in serum is an effective means of diagnosing hepatotoxicity.
[0003] In recent years, fluorescence methods based on chromophore changes have been widely used in ONOO due to their high sensitivity, simple operation, and good selectivity. - However, most of the current detection of ONOO - The fluorescent probe is a change in a single fluorescent signal, which is easily interfered by external factors such as biological background, excitation light fluctuations, environment and instruments, resulting in unsatisfactory detection results.
[0004] The ratio fluorescence method can effectively eliminate the interference of fluorescence intensity data distortion caused by objective factors such as environment and instruments through the built-in fluorescence reference, thereby improving the sensitivity and accuracy of the fluorescence sensor. In addition, ratio fluorescence is often accompanied by obvious changes in fluorescence color. The eyes are more sensitive to changes in fluorescence color, which is conducive to the direct observation of the presence of the analyte with the naked eye. Therefore, the preparation of ratio-type ONOO - Fluorescent probes are imminent. Summary of the invention
[0005] The purpose of the present invention is to provide a ratio fluorescence detection hepatotoxicity marker - ONOO in view of the shortcomings of the current technology. - Rare earth-organic framework probe and its preparation method and application. This method constructs a rare earth-organic framework probe by assembling amino-functionalized organic ligands with rare earth ions. Through naked eye observation and simple fluorescence intensity comparison, ONOO can be quickly and accurately judged. - The present invention has excellent selectivity and has no fluorescence response to substances that may coexist with common salts and amino acids, such as sodium bromide, sodium carbonate, potassium chloride, magnesium chloride, sodium bicarbonate, calcium chloride, glutamic acid, L-cysteine, glutathione and L-proline. At the same time, the response to potential interferents, such as hypochlorite, hydrogen peroxide, nitrite, singlet oxygen, hydroxyl radicals and tert-butyl hydroperoxide, can be ignored; and the probe can be used to detect ONOO in serum samples of mice with liver damage. - Detection.
[0006] The technical solution of the present invention is:
[0007] A ratiometric fluorescence assay for ONOO, a hepatotoxicity marker - A rare earth-organic framework probe, the probe comprising a solute and a solvent, the solute being a rare earth-organic framework, and the solvent being physiological saline;
[0008] The mass concentration of the solute is 0.01-0.08 mg / mL; the mass percentage concentration of the physiological saline is 0.9%-1.8%.
[0009] The organic refers to an organic ligand, which is 2-aminoterephthalic acid, 2'-amino-[1,1':4',1"-terphenyl]-3,3",5,5"-tetracarboxylic acid or 2'-amino-[1,1':4',1"-terphenyl]-4,4"-dicarboxylic acid;
[0010] The rare earth mentioned here refers to rare earth ions, which are Ln 3+ :Nd 3+ 、Sm 3+ 、Eu 3+ , Gd 3+ , Tb 3+ 、Dy 3+ 、Ho 3+ , Er 3+ 、Tm 3+ or Yb 3+ .
[0011] The method for preparing the rare earth-organic framework comprises the following steps:
[0012] Adding the organic ligand and the rare earth compound into the mixed solvent, stirring for 30 to 50 minutes, heating to 80 to 110° C. and continuing the reaction for 60 to 80 hours, washing the obtained crystals with N,N-dimethylformamide to obtain a rare earth-organic framework;
[0013] The molar ratio of the organic ligand to the rare earth compound is 1-4.5:1-4.5; the concentration of the rare earth ions in the mixed solution is 10-45 mM;
[0014] The mixed solvent consists of N,N-dimethylformamide, water and sulfuric acid. For every 1-3 mL of N,N-dimethylformamide, 1-3 mL of water and 10-50 μL of sulfuric acid are added. The mass concentration of the sulfuric acid is 90%-98%.
[0015] The rare earth compounds are nitrates and chlorides of rare earth elements.
[0016] Ratiometric fluorescence detection of hepatotoxicity marker - ONOO - The method for preparing a rare earth-organic framework probe comprises the following steps:
[0017] The rare earth-organic framework is ground for 20 to 40 minutes, centrifuged at 11000 r / min for 3 to 10 minutes, and then added to physiological saline to obtain a rare earth-organic framework probe;
[0018] The concentration of the rare earth-organic framework in physiological saline is 0.01-0.08 mg / mL;
[0019] Ratiometric fluorescence detection of hepatotoxicity marker - ONOO - The application method of the rare earth-organic framework probe comprises the following steps:
[0020] Add the test solution dropwise into the rare earth-organic framework probe, wait for 30 to 60 seconds, and observe the color under a 365 nm ultraviolet lamp. If red appears, it means that the test solution does not contain ONOO - ; blue means the solution contains ONOO - ;
[0021] Wherein, the volume ratio of the solution to be tested and the rare earth-organic framework probe is 1:0.00033-0.01;
[0022] If the test solution contains ONOO - , then ONOO can be tested - The concentration range of the probe was 0.0054-112 μM; in addition, the probe could detect ONOO in serum samples of mice with liver injury. - The detected concentration is in the pathological range (50~100×10 -6 M).
[0023] The solution to be tested contains ONOO - and a solution of other selective substances, wherein the selective components are one or more of sodium bromide, sodium carbonate, potassium chloride, magnesium chloride, sodium bicarbonate, calcium chloride, glutamic acid, L-cysteine, glutathione, L-proline, hypochlorite, hydrogen peroxide, nitrite, singlet oxygen, hydroxyl free radical and tert-butyl hydroperoxide.
[0024] The essential features of the present invention are:
[0025] The present invention utilizes ONOO - The oxidizing property of ONOO can oxidize the amino group in the amino-functionalized organic ligand to nitroso group, which changes the fluorescence of the organic ligand. After the amino-functionalized organic ligand is oxidized to nitroso group, the triplet energy level of the organic ligand changes, and the energy level difference between the organic ligand and the rare earth ion becomes larger, which reduces the energy transfer to the rare earth ion and causes the luminescence of the rare earth ion to weaken. Moreover, as ONOO - As the concentration gradually increases, the fluorescence intensity of rare earth ions will be significantly weakened, while the luminescence of organic ligands will be significantly enhanced.
[0026] The beneficial effects of the present invention are:
[0027] (1) Previous fluorescence detection of ONOO - The research of ONOO often requires the preparation of fine nanoparticles or small molecule probes, and most of them are single fluorescence signal changes, which are easily interfered by external factors such as biological background, excitation light fluctuations, environment and instruments. The ratio fluorescence probe prepared by the present invention can effectively eliminate the interference of fluorescence intensity data distortion caused by objective factors such as environment and instruments through the built-in fluorescence reference, thereby improving the sensitivity and accuracy of the fluorescence sensor, and by observing the changes in fluorescence color with the naked eye, it can quickly and accurately judge ONOO - existence.
[0028] (2) In addition, the probe has no fluorescence response to common salts and amino acids that may coexist, such as sodium bromide, sodium carbonate, potassium chloride, magnesium chloride, sodium bicarbonate, calcium chloride, glutamic acid, L-cysteine, glutathione and L-proline. At the same time, the response to potential interferences, such as hypochlorite, hydrogen peroxide, nitrite, singlet oxygen, hydroxyl radicals, and tert-butyl hydroperoxide can be ignored, so this method has good selectivity.
[0029] (3) The present invention can achieve the reduction of trace amounts of ONOO within 45 seconds. - Rapid detection, the detection limit can reach 5.4nM, this is a rare earth fluorescent probe to detect ONOO - The minimum detection limit achieved; and the present invention is also used for ONOO in serum samples of liver-damaged mice- The detection limit in normal mouse serum was 17.5 nM, which was below the pathological range, indicating that it can be used to detect ONOO in serum samples of liver-damaged mice. - The ONOO in serum samples of three mice with liver injury was detected. - The concentration was quantified and the detected concentrations were all within the pathological range (50-100×10 -6 M), demonstrating that the probe can detect ONOO by ratiometric fluorescence. - credibility. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 Add ONOO to the main dispersion in Example 1 - Excitation spectrum after .
[0031] Figure 2 This is the fluorescence emission spectrum of the main dispersion in Example 1 during the fluorescence titration process.
[0032] Figure 3 The main dispersion in Example 1 is ONOO in the fluorescence titration process. - The concentration is the horizontal axis, and the fluorescence intensity ratio at 616nm and 410nm (I 616 / I 410 ) is the linear fitting graph with y-axis.
[0033] Figure 4 The main dispersion liquid in Example 1 is ONOO - Response kinetics diagram.
[0034] Figure 5 The main dispersion liquid in Example 1 is ONOO - Selective bar chart. (1-18 are ONOO - , blank, sodium bromide, sodium carbonate, potassium chloride, magnesium chloride, sodium bicarbonate, calcium chloride, glutamic acid, L-cysteine, glutathione, L-proline, hypochlorite, hydrogen peroxide, nitrite, singlet oxygen, hydroxyl radical, and tert-butyl hydroperoxide).
[0035] Figure 6 This is the fluorescence emission spectrum in normal mouse serum in Example 1.
[0036] Figure 7 This is a fluorescence emission spectrum of the probe dispersion in Example 1 during fluorescence titration in normal mouse serum.
[0037] Figure 8 The probe dispersion in Example 1 was used as ONOO in the normal mouse serum fluorescence titration process. -The concentration is the horizontal axis, and the fluorescence intensity ratio at 616nm and 410nm (I 616 / I 410 ) is the linear fit of the vertical axis.
[0038] Fig. 9 The asterisk is the fluorescence intensity ratio (I) of the probe at 616 nm to 410 nm in the serum fluorescence intensity test of normal and liver-injured mice in Example 1. 616 / I 410 )and Figure 8 The ONOO levels in serum of normal and liver-damaged mice were obtained by linear equation fitting and calculation. - concentration. DETAILED DESCRIPTION
[0039] In order to more clearly illustrate the present invention, the following examples are given, but they do not limit the scope of the invention in any way.
[0040] The rare earth-organic framework described in the present invention: Eu-BDC-NH2 is a known material. The specific method for obtaining it can be seen in Pengda Yi, Hongliang Huang*, Yaguang Peng, Dahuan Liu* and Chongli Zhong. A series of europium-based metal organic frameworks with tuned intrinsic luminescence properties and detection RSC Adv.,2016,6,111934-111941.
[0041] The structural formula of the organic ligand H2BDC-NH2 (2-aminoterephthalic acid) is as follows:
[0042]
[0043] The rare earth-organic framework: EuTPTC-NH2 described in the present invention is a known material. The specific method for obtaining it can be seen in Kuangli Yu, Qin Wang, Wenqing Xiang, Zhangjian Li, Yabing He,* and Dian Zhao*. Amino-Functionalized Single-Lanthanide Metal-Organic Framework as a Ratiometric Fluorescent Sensor for Quantitative Visual Detection of Fluoride Ions. Inorg. Chem., 2022, 61, 13627-13636.
[0044] The structural formula of the organic ligand H4TPTC-NH2 (2'-amino-[1,1':4',1"-terphenyl]-3,3",5,5"-tetracarboxylic acid) is as follows:
[0045]
[0046] But it is not limited to this.
[0047] Example 1
[0048] (1) Accurately weigh 21 mg, 0.168 mmol 2'-amino-[1,1':4',1"-terphenyl]-3,3",5,5"-tetracarboxylic acid and 75 mg, 0.05 mmol europium nitrate hexahydrate and disperse them in a mixed solution of 2.5 mL N,N-dimethylformamide, 1.5 mL water and 25 μL sulfuric acid (mass concentration is 98%), stir at room temperature for 50 minutes until completely dissolved and no bubbles are present, maintain in an oven at 90° C. for 72 hours, wash the obtained crystals with N,N-dimethylformamide 5 times, grind for 30 minutes, and centrifuge at 11000 r / min for 5 minutes. The precipitate is the rare earth-organic framework;
[0049] 0.06 mg of the precipitate was dispersed in 3 mL of physiological saline (0.9%) to obtain a rare earth-organic framework probe, which was recorded as the main dispersion liquid (calculated: the concentration of the main dispersion liquid was 0.02 mg / mL).
[0050] (2) Take 3 mL of the main dispersion in a quartz cell, stir evenly, and measure the blank fluorescence emission spectrum 11 times at an excitation wavelength of 313 nm. Use a 1 μL injector to add different concentrations of ONOO -Solution (fluorescence titration). Fluorescence test was performed using a British Edinburgh FS920P spectrometer to measure fluorescence spectra, using a 450W xenon lamp as the excitation light source, equipped with a dual excitation monochromator, an emission monochromator, and a semiconductor-cooled Hamamatsu RMP928 photomultiplier tube. Fluorescence emission spectra were measured with 313nm as the maximum excitation wavelength and 616nm as the maximum emission wavelength.
[0051] We conducted a series of embodiments by increasing the concentration of ONOO in step (2). - The concentration of the solution, a series of fluorescence data were measured, and the corresponding fluorescence data will also change, as shown in Table 1:
[0052]
[0053] ONOO - The concentration is the horizontal axis, and the fluorescence intensity ratio at 616nm and 410nm (I 616 / I 410 ) is used as the vertical axis for linear fitting.
[0054] Figures 2-3 is the fluorescence emission spectrum of the main dispersion during the fluorescence titration process and I 616 / I 410 About ONOO - The linear relationship diagram of the concentration shows that as ONOO - With the increase of concentration, the I 616 / I 410 Gradually increases, the two are linearly related, R 2 =0.998, and the detection limit can be calculated to be 5.4 nM based on the signal-to-noise ratio of 3.
[0055] In addition, the naked eye can see that under 365nm UV light, 120μM ONOO - The main dispersion of the solution is red, and 120 μM ONOO is added. - After 45 seconds, the main dispersion of the solution turns blue.
[0056] Figure 4 Add ONOO to the main dispersion - During the process, the intensity of organic ligands and rare earth ions changes. It can be seen from the figure that organic ligands and rare earth ions are - After 45 seconds, the strength remained unchanged, indicating that the main dispersion liquid was - The detection is completed within 45 seconds.
[0057] (3) Take 3 mL of the main dispersion in a quartz cell and stir evenly. Prepare 17 more identical solutions (a total of 18 identical solutions). Select one and add 10 μL of 36 mM ONOO - , 16 different interference solutions (sodium bromide, sodium carbonate, potassium chloride, magnesium chloride, sodium bicarbonate, calcium chloride, glutamic acid, L-cysteine, glutathione, L-proline, hypochlorite, hydrogen peroxide, nitrite, singlet oxygen, hydroxyl radical and tert-butyl hydroperoxide) were added to the other 16 solutions (at this time, ONOO - The concentration of each interfering solution was 120 μM), stirred evenly, and the fluorescence emission spectrum was measured at the maximum excitation wavelength of 313 nm and the maximum emission wavelength of 616 nm.
[0058] Figure 5 Add ONOO to the main dispersion - The fluorescence intensity ratio of the solution, blank solution and interference solution at 616 nm to 410 nm (I 616 / I 410 ), it can be seen from the figure that the main dispersion liquid has an effect on ONOO - The solution has a very significant fluorescence response, proving that the main dispersion only recognizes ONOO - In addition, under 365nm ultraviolet light, it can be observed with the naked eye that only when ONOO - The main dispersion after elution is blue, and the rest are red.
[0059] (4) Take 1.5 mL of 0.02 mg / mL main dispersion in a quartz cell, add 1.5 mL of normal mouse serum (the concentration of the probe dispersion in the quartz cell is 0.01 mg / mL at this time, recorded as the probe dispersion), stir evenly, and measure the blank fluorescence emission spectrum 11 times at an excitation wavelength of 313 nm. Use a 1 μL injector to add different concentrations of ONOO - Solution (fluorescence titration). Fluorescence test was performed using a British Edinburgh FS920P spectrometer to measure fluorescence spectra, using a 450W xenon lamp as the excitation light source, equipped with a dual excitation monochromator, an emission monochromator, and a semiconductor-cooled Hamamatsu RMP928 photomultiplier tube. Fluorescence emission spectra were measured with 313nm as the maximum excitation wavelength and 616nm as the maximum emission wavelength.
[0060] We conducted a series of embodiments by increasing the concentration of ONOO in step (4). - The concentration of the solution, a series of fluorescence data were measured, and the corresponding fluorescence data will also change, as shown in Table 2:
[0061]
[0062] ONOO - The concentration is the horizontal axis, and the fluorescence intensity ratio at 616nm and 410nm (I 616 / I 410 ) is used as the vertical axis for linear fitting.
[0063] Figures 7-8 is the fluorescence emission spectrum of the probe dispersion during the fluorescence titration process and I 616 / I 410 About ONOO - The linear relationship diagram of the concentration shows that as ONOO - With the increase of concentration, the I 616 / I 410 Gradually increases, the two are linearly related, R 2 =0.993, and the detection limit can be calculated to be 17.5 nM from the signal-to-noise ratio of 3. In addition, it can be seen by the naked eye that when 180 μM ONOO - The main dispersion before the solution is red, add ONOO - After waiting for 45 seconds, the main dispersion liquid turns blue-cyan.
[0064] (5) Add 1.5 mL of 0.08 mg / mL main dispersion to three portions of liver injury mouse serum and one portion of normal mouse serum equal to those in step (4), wait for 45 seconds, and measure the fluorescence intensity ratio (I) at 616 nm to that at 410 nm under the same conditions as step (4). 616 / I 410 )and Figure 7 The linear relationship between the ONOO in serum of liver-damaged and normal mice was obtained. - The concentration ( Fig. 9 The asterisk indicates that ONOO was detected in three samples of liver injury mouse serum and one sample of normal mouse serum. - concentration) and compared with ONOO in pathological conditions - Concentration (50~100×10 -6 M) Compare and determine the credibility of this method.
[0065] Example 2
[0066] Steps (1) (2) (3) (4) (5) are the same as in Example 1, except that the 2'-amino-[1,1':4',1"-terphenyl]-3,3",5,5"-tetracarboxylic acid in step (1) is replaced with 2-aminoterephthalic acid. Other conditions remain unchanged, and ONOO is carried out using the main dispersion. -Identification and detection. Under ultraviolet light, the fluorescence brightness of the main dispersion has changed significantly. The ratio of fluorescence intensity has also been greatly improved.
[0067] Example 3
[0068] Steps (1)(2)(3)(4)(5) are the same as in Example 1, except that the 2'-amino-[1,1':4',1"-terphenyl]-3,3",5,5"-tetracarboxylic acid in step (1) is replaced with 2'-amino-[1,1':4',1"-terphenyl]-4,4"-dicarboxylic acid. Other conditions remain unchanged, and ONOO is carried out using the main dispersion. - Identification and detection. Under ultraviolet light, the fluorescence brightness of the main dispersion has changed significantly. The ratio of fluorescence intensity has also been greatly improved.
[0069] Example 4
[0070] Steps (1) (2) (3) (4) (5) are the same as in Example 1, except that the europium nitrate hexahydrate aqueous solution in step (1) is replaced with a terbium nitrate hexahydrate aqueous solution, and 2'-amino-[1,1':4',1"-terphenyl]-3,3",5,5"-tetracarboxylic acid is replaced with 2-aminoterephthalic acid. Other conditions remain unchanged, and ONOO is carried out using the main dispersion in the same manner. - Identification and detection. Under ultraviolet light, the fluorescence brightness of the main dispersion has changed significantly. The ratio of fluorescence intensity has also been greatly improved.
[0071] Example 5
[0072] Steps (1) (2) (3) (4) (5) are the same as in Example 1, except that the europium nitrate hexahydrate aqueous solution in step (1) is replaced with a neodymium trichloride aqueous solution, and 2'-amino-[1,1':4',1"-terphenyl]-3,3",5,5"-tetracarboxylic acid is replaced with 2-aminoterephthalic acid. Other conditions remain unchanged, and ONOO is carried out using the main dispersion in the same manner. - Identification and detection. Under ultraviolet light, the fluorescence brightness of the main dispersion has changed significantly. The ratio of fluorescence intensity has also been greatly improved.
[0073] Example 6
[0074] Steps (1) (2) (3) (4) (5) are the same as in Example 1, except that the europium nitrate hexahydrate aqueous solution in step (1) is replaced with a samarium chloride aqueous solution, and other conditions remain unchanged. ONOO is also carried out using the main dispersion. - Identification and detection. Under ultraviolet light, the fluorescence brightness of the main dispersion has changed significantly. The ratio of fluorescence intensity has also been greatly improved.
[0075] Example 7
[0076] Steps (1), (2), (3), (4), and (5) are the same as in Example 1, except that the europium nitrate hexahydrate aqueous solution in step (1) is replaced with a gadolinium chloride aqueous solution, and other conditions remain unchanged. ONOO is also carried out using the main dispersion. - Identification and detection. Under ultraviolet light, the fluorescence brightness of the main dispersion has changed significantly. The ratio of fluorescence intensity has also been greatly improved.
[0077] Example 8
[0078] Steps (1) (2) (3) (4) (5) are the same as in Example 1, except that the europium nitrate hexahydrate aqueous solution in step (1) is replaced with a dysprosium chloride aqueous solution, and other conditions remain unchanged. ONOO is also carried out using the main dispersion. - Identification and detection. Under ultraviolet light, the fluorescence brightness of the main dispersion has changed significantly. The ratio of fluorescence intensity has also been greatly improved.
[0079] Example 9
[0080] Steps (1) (2) (3) (4) (5) are the same as in Example 1, except that the europium nitrate hexahydrate aqueous solution in step (1) is replaced with an erbium chloride aqueous solution, and other conditions remain unchanged. ONOO is also carried out using the main dispersion. - Identification and detection. Under ultraviolet light, the fluorescence brightness of the main dispersion has changed significantly. The ratio of fluorescence intensity has also been greatly improved.
[0081] Example 10
[0082] Steps (1) (2) (3) (4) (5) are the same as in Example 1, except that the europium nitrate hexahydrate aqueous solution in step (1) is replaced with a thulium trichloride aqueous solution, and other conditions remain unchanged. ONOO is also carried out using the main dispersion. - Identification and detection. Under ultraviolet light, the fluorescence brightness of the main dispersion has changed significantly. The ratio of fluorescence intensity has also been greatly improved.
[0083] Embodiment 11
[0084] Steps (1) (2) (3) (4) (5) are the same as in Example 1, except that the europium nitrate hexahydrate aqueous solution in step (1) is replaced with an ytterbium chloride aqueous solution, and other conditions remain unchanged. ONOO is also carried out using the main dispersion. - Identification and detection. Under ultraviolet light, the fluorescence brightness of the main dispersion has changed significantly. The ratio of fluorescence intensity has also been greatly improved.
[0085] In summary, the present invention constructs a rare earth-organic framework probe by assembling amino-functionalized organic ligands and rare earth ions to achieve ONOO -The detection limit is 5.4nM. The probe has no fluorescence response to common salts and amino acids that may coexist, such as sodium bromide, sodium carbonate, potassium chloride, magnesium chloride, sodium bicarbonate, calcium chloride, glutamic acid, L-cysteine, glutathione and L-proline. At the same time, the response to potential interferents, such as hypochlorite, hydrogen peroxide, nitrite, singlet oxygen, hydroxyl radical, and tert-butyl hydroperoxide can be ignored. In addition, the probe can also be used for ONOO in serum samples of mice with liver damage. - The detection concentration is in the pathological range (50~100×10 -6 M), demonstrating that the probe can be used for ratiometric fluorescence detection of ONOO - credibility.
[0086] From the above examples, it can be seen that the present invention forms a rare earth-organic framework by modifying the amino group on the organic ligand and assembling it with the rare earth ion. Since the rare earth-organic framework is a kind of material with high porosity, high specific surface area, structural diversity and tunability, there are many open binding sites that can be used as recognition sites, which provides the possibility for high-sensitivity and specific recognition of the analyte. When ONOO is added - When ONOO - The oxidizing property of the nitrosamine oxidizes the amino group to the nitrosamine, which changes the fluorescence of the organic ligand. After being oxidized to the nitrosamine, the triplet energy level of the organic ligand changes, and the energy level difference between the organic ligand and the rare earth ion increases, which reduces the energy transfer to the rare earth ion, thus causing the fluorescence of the rare earth ion to weaken. The sensitivity of the fluorescence intensity and the intuitive color change under ultraviolet light can be used to quickly detect ONOO - , with a detection limit of 5.4 nM. In addition, the probe has no fluorescence response to common salts and amino acids that may coexist, such as sodium bromide, sodium carbonate, potassium chloride, magnesium chloride, sodium bicarbonate, calcium chloride, glutamic acid, L-cysteine, glutathione and L-proline. At the same time, the response to potential interferents such as hypochlorite, hydrogen peroxide, nitrite, singlet oxygen, hydroxyl radicals and tert-butyl hydroperoxide can be ignored. ONOO - The probe can be used to detect ONOO in serum samples of mice with liver damage. - The detection concentration is in the pathological range (50~100×10 -6 M), demonstrating that the probe can be used for ratiometric fluorescence detection of ONOO - credibility.
[0087] Matters not covered by the present invention are known technologies.
Claims
1. A ratiometric fluorescence assay for ONOO, a hepatotoxicity marker - Rare earth-organic framework probes, Its characteristics are The probe includes a solute and a solvent, wherein the solute is a rare earth-organic framework and the solvent is physiological saline; The mass concentration of the solute is 0.01 to 0.08 mg / mL; the mass percentage concentration of the physiological saline is 0.9% to 1.8%; The organic refers to an organic ligand, which is 2-aminoterephthalic acid, 2'-amino-[1,1':4',1"-terphenyl]-3,3",5,5"-tetracarboxylic acid or 2'-amino-[1,1':4',1"-terphenyl]-4,4"-dicarboxylic acid; The rare earth refers to rare earth ions, which are Ln 3+ :Nd 3+ 、Sm 3+ 、Eu 3+ , Gd 3+ , Tb 3+ 、Dy 3+ 、Ho 3+ , Er 3+ 、Tm 3+ or Yb 3+ .
2. The ratiometric fluorescence detection of hepatotoxicity marker-ONOO as claimed in claim 1 - The rare earth-organic framework probe is characterized by a preparation method of the rare earth-organic framework, comprising the following steps: Adding the organic ligand and the rare earth compound into the mixed solvent, stirring for 30 to 50 minutes, heating to 80 to 110° C. and continuing the reaction for 60 to 80 hours, washing the obtained crystals with N,N-dimethylformamide to obtain a rare earth-organic framework; in, The molar ratio of the organic ligand to the rare earth compound is 1-4.5:1-4.5; the concentration of the rare earth ions in the mixed solution is 10-45 mM; The mixed solvent is composed of N,N-dimethylformamide, water and sulfuric acid, and 1-3 mL of water and 10-50 μL of sulfuric acid are added to every 1-3 mL of N,N-dimethylformamide; the mass concentration of sulfuric acid is 90% to 98%; The rare earth compounds are nitrates and chlorides of rare earth elements.
3. The ratiometric fluorescence detection hepatotoxicity marker-ONOO as claimed in claim 1 - Preparation method of rare earth-organic framework probe, Its characteristics are The steps include: The rare earth-organic framework is ground for 20 to 40 minutes, centrifuged at 11000 r / min for 3 to 10 minutes, and then added to physiological saline to obtain a rare earth-organic framework probe; The concentration of the rare earth-organic framework in physiological saline is 0.01-0.08 mg / mL.
4. The ratiometric fluorescence detection of hepatotoxicity marker-ONOO as claimed in claim 1 - The application method of the rare earth-organic framework probe is characterized by The following steps are involved: Add the test solution dropwise into the rare earth-organic framework probe, wait for 30 to 60 seconds, and observe the color under a 365 nm ultraviolet lamp. If red appears, it means that the test solution does not contain ONOO - ; Turning blue means that the solution contains ONOO-; The volume ratio of the solution to be tested and the rare earth-organic framework probe is 1:0.00033-0.
01.
5. The ratiometric fluorescence detection of hepatotoxicity marker-ONOO as claimed in claim 4 - The application method of the rare earth-organic framework probe is characterized in that if the solution to be tested contains ONOO - , the concentration range of ONOO- that can be tested is 0.0054~112μM.
6. The ratiometric fluorescence detection of hepatotoxicity marker-ONOO as claimed in claim 1 - The application method of the rare earth-organic framework probe is characterized in that the solution to be tested contains ONOO - and a solution of other selective substances, wherein the selective components are one or more of sodium bromide, sodium carbonate, potassium chloride, magnesium chloride, sodium bicarbonate, calcium chloride, glutamic acid, L-cysteine, glutathione, L-proline, hypochlorite, hydrogen peroxide, nitrite, singlet oxygen, hydroxyl free radical and tert-butyl hydroperoxide.
